Posted in | News | Chemical Sensor

Homeland Security Orders Morpho Explosives Trace Detection Systems

The Transportation Security Administration (TSA) of the U.S. Department of Homeland Security has placed an order for more Itemiser DX explosives trace detection (ETD) solutions from the security business division of the Safran group, Morpho Detection. The order quantity that exceeds 1,200 ETD systems is worth more than $35 million. The TSA order was awarded on the conclusion of a competitive contracting process.

This repeat order results in more than 1,600 Itemiser DX units bought by TSA during the last year as part of contracts worth more than $50 million.

Morpho Detection Itemiser DX

The Itemiser DX, based on the Ion Trap Mobility Spectroscopy (ITMS), offers matchless contraband and threat detection functionality and is optimal for cargo, checkpoint and checked baggage screening.

TSA will use the Itemiser DX at U.S. airports. This easy-to-use, effective and lightweight Itemiser DX complies with the strict detection standards as stipulated by TSA. The American Recovery and Reinvestment Act (ARRA) funded the TSA order placed on Morpho. Besides offering improved detection capabilities for the protection of cargo and travelers as per the ARRA program, this order will also result in creating jobs in the U.S.

The Itemiser DX was initially placed in the qualified products list of TSA for cargo and checkpoint screening during March 2009. It provides qualified explosives detection functionality in a user-friendly, dependable, cost-effective and portable desktop package.

Morpho Detection’s CEO and President Dennis Cooke informed that Morpho is proud in TSA’s confidence in the ability of Itemiser DX to enable the protection of air travelers by awarding the repeat order in one year. He lauded the initiatives of TSA to provide better and more enhanced explosive detection capabilities for the airports in the U.S.

Source: http://www.morphodetection.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.